Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	-	SEMA7A WDR7 NBEAL1 SEC31B DMXL1 SHKBP1 SORT1 WDR38 PLAA NLE1 WDR12 WDR86 SPAG16	5.68e-06	333	159	13	2.130.10.10
Domain	Anaphylatoxin_comp_syst	C4A C4B C5	5.98e-06	5	159	3	IPR018081
Domain	Anaphylatoxn_comp_syst_dom	C4A C4B C5	5.98e-06	5	159	3	IPR001840
Domain	WD40/YVTN_repeat-like_dom	SEMA7A WDR7 NBEAL1 SEC31B DMXL1 SHKBP1 SORT1 WDR38 PLAA NLE1 WDR12 WDR86 SPAG16	6.06e-06	335	159	13	IPR015943
Domain	WD40	WDR7 NBEAL1 SEC31B DMXL1 SHKBP1 WDR38 PLAA NLE1 WDR12 WDR86 SPAG16	1.40e-05	259	159	11	PF00400
Domain	WD40	WDR7 NBEAL1 SEC31B DMXL1 SHKBP1 WDR38 PLAA NLE1 WDR12 WDR86 SPAG16	1.92e-05	268	159	11	SM00320
Domain	ANATO	C4A C4B C5	2.07e-05	7	159	3	SM00104
Domain	ANAPHYLATOXIN_2	C4A C4B C5	2.07e-05	7	159	3	PS01178
Domain	ANAPHYLATOXIN_1	C4A C4B C5	2.07e-05	7	159	3	PS01177
Domain	ANATO	C4A C4B C5	2.07e-05	7	159	3	PF01821
Domain	Anaphylatoxin/fibulin	C4A C4B C5	2.07e-05	7	159	3	IPR000020
Domain	WD40_repeat	WDR7 NBEAL1 SEC31B DMXL1 SHKBP1 WDR38 PLAA NLE1 WDR12 WDR86 SPAG16	2.20e-05	272	159	11	IPR001680
Domain	WD_REPEATS_1	WDR7 NBEAL1 SEC31B DMXL1 SHKBP1 WDR38 PLAA NLE1 WDR12 WDR86 SPAG16	2.69e-05	278	159	11	PS00678
Domain	WD_REPEATS_2	WDR7 NBEAL1 SEC31B DMXL1 SHKBP1 WDR38 PLAA NLE1 WDR12 WDR86 SPAG16	2.78e-05	279	159	11	PS50082
Domain	WD_REPEATS_REGION	WDR7 NBEAL1 SEC31B DMXL1 SHKBP1 WDR38 PLAA NLE1 WDR12 WDR86 SPAG16	2.78e-05	279	159	11	PS50294
Domain	WD40_repeat_dom	WDR7 NBEAL1 SEC31B DMXL1 SHKBP1 WDR38 PLAA NLE1 WDR12 WDR86 SPAG16	4.91e-05	297	159	11	IPR017986
Domain	A2M	C4A C4B C5	6.95e-05	10	159	3	PF00207
Domain	A2M_N_2	C4A C4B C5	6.95e-05	10	159	3	IPR011625
Domain	A2M_comp	C4A C4B C5	6.95e-05	10	159	3	IPR011626
Domain	A2M_recep	C4A C4B C5	6.95e-05	10	159	3	PF07677
Domain	A2M_comp	C4A C4B C5	6.95e-05	10	159	3	PF07678
Domain	A2M_N	C4A C4B C5	6.95e-05	10	159	3	PF01835
Domain	A2M_N	C4A C4B C5	6.95e-05	10	159	3	IPR002890
Domain	A-macroglobulin_rcpt-bd	C4A C4B C5	6.95e-05	10	159	3	IPR009048
Domain	ALPHA_2_MACROGLOBULIN	C4A C4B C5	6.95e-05	10	159	3	PS00477
Domain	A2M_N_2	C4A C4B C5	6.95e-05	10	159	3	PF07703
Domain	Macroglobln_a2	C4A C4B C5	6.95e-05	10	159	3	IPR001599
Domain	Cyt_P450_E_grp-I_CYP1	CYP1A1 CYP1A2	7.20e-05	2	159	2	IPR008066
Domain	NLE	NLE1 WDR12	7.20e-05	2	159	2	IPR012972
Domain	NLE	NLE1 WDR12	7.20e-05	2	159	2	PF08154
Domain	HIP1_clath_bdg	HIP1 HIP1R	7.20e-05	2	159	2	PF16515
Domain	HIP1_clath-bd	HIP1 HIP1R	7.20e-05	2	159	2	IPR032422
Domain	Sla2_fam	HIP1 HIP1R	7.20e-05	2	159	2	IPR030224
Domain	DUF719	FAM114A1 FAM114A2	7.20e-05	2	159	2	IPR007998
Domain	DUF719	FAM114A1 FAM114A2	7.20e-05	2	159	2	PF05334
Domain	ARM-type_fold	STK36 HIP1 ATR NBEAL1 SCYL1 HUWE1 RALGAPA2 TRIP12 PPP2R1A PLAA PPP6R3	1.59e-04	339	159	11	IPR016024
Domain	Rhs_assc_core	TENM2 TENM4	2.15e-04	3	159	2	IPR022385
Domain	-	TENM2 TENM4 LRP2 SORL1	3.30e-04	39	159	4	2.120.10.30
Domain	C345C	C4A C4B C5	3.77e-04	17	159	3	SM00643
Domain	ILWEQ_dom	HIP1 HIP1R	4.27e-04	4	159	2	IPR002558
Domain	Tox-GHH_dom	TENM2 TENM4	4.27e-04	4	159	2	IPR028916
Domain	ILWEQ	HIP1 HIP1R	4.27e-04	4	159	2	SM00307
Domain	ANTH_dom	HIP1 HIP1R	4.27e-04	4	159	2	IPR011417
Domain	ILWEQ	HIP1 HIP1R	4.27e-04	4	159	2	PD011820
Domain	Tox-GHH	TENM2 TENM4	4.27e-04	4	159	2	PF15636
Domain	ANTH	HIP1 HIP1R	4.27e-04	4	159	2	PF07651
Domain	-	HIP1 HIP1R	4.27e-04	4	159	2	1.20.1410.10
Domain	I_LWEQ	HIP1 HIP1R	4.27e-04	4	159	2	PF01608
Domain	I_LWEQ	HIP1 HIP1R	4.27e-04	4	159	2	PS50945
Domain	Ten_N	TENM2 TENM4	4.27e-04	4	159	2	IPR009471
Domain	Ten_N	TENM2 TENM4	4.27e-04	4	159	2	PF06484
Domain	-	C4A C5	4.27e-04	4	159	2	1.20.91.20
Domain	TENEURIN_N	TENM2 TENM4	4.27e-04	4	159	2	PS51361
Domain	Terpenoid_cyclase/PrenylTrfase	C4A C4B C5	4.50e-04	18	159	3	IPR008930
Domain	WD40_repeat_CS	WDR7 SEC31B WDR38 NLE1 WDR12 WDR86 SPAG16	5.17e-04	164	159	7	IPR019775
Domain	NTR	C4A C4B C5	5.31e-04	19	159	3	PF01759
Domain	Netrin_module_non-TIMP	C4A C4B C5	5.31e-04	19	159	3	IPR018933
Domain	ConA-like_dom	TRIM49 COL12A1 NBEAL1 TRIM49C LAMA3 ASH2L HNRNPUL2 TRIM49B	5.86e-04	219	159	8	IPR013320
Domain	6-blade_b-propeller_TolB-like	TENM2 TENM4 LRP2 SORL1	6.25e-04	46	159	4	IPR011042
Domain	Sortilin_C	SORT1 SORL1	7.08e-04	5	159	2	PF15901
Domain	Sortilin-Vps10	SORT1 SORL1	7.08e-04	5	159	2	PF15902
Domain	VPS10	SORT1 SORL1	7.08e-04	5	159	2	IPR006581
Domain	Sortilin_N	SORT1 SORL1	7.08e-04	5	159	2	IPR031778
Domain	Sortilin_C	SORT1 SORL1	7.08e-04	5	159	2	IPR031777
Domain	YD	TENM2 TENM4	7.08e-04	5	159	2	IPR006530
Domain	RII_binding_1	AKAP12 AKAP13	7.08e-04	5	159	2	PF10522
Domain	VPS10	SORT1 SORL1	7.08e-04	5	159	2	SM00602
Domain	RII_binding_1	AKAP12 AKAP13	7.08e-04	5	159	2	IPR018459
Domain	HEAT	STK36 ATR SCYL1 PPP2R1A	7.35e-04	48	159	4	PF02985
Domain	G-protein_beta_WD-40_rep	WDR38 NLE1 WDR12 WDR86 SPAG16	7.96e-04	85	159	5	IPR020472
Domain	SPRY	TRIM49 TRIM49C ASH2L HNRNPUL2 TRIM49B	8.85e-04	87	159	5	SM00449
Domain	NTR	C4A C4B C5	9.46e-04	23	159	3	PS50189
Domain	Netrin_domain	C4A C4B C5	9.46e-04	23	159	3	IPR001134
Domain	RBD	RAF1 ARAF	1.06e-03	6	159	2	PF02196
Domain	SPRY	TRIM49 TRIM49C ASH2L HNRNPUL2 TRIM49B	1.25e-03	94	159	5	PF00622
Domain	SPRY_dom	TRIM49 TRIM49C ASH2L HNRNPUL2 TRIM49B	1.25e-03	94	159	5	IPR003877
Domain	B30.2/SPRY	TRIM49 TRIM49C ASH2L HNRNPUL2 TRIM49B	1.31e-03	95	159	5	IPR001870
Domain	B302_SPRY	TRIM49 TRIM49C ASH2L HNRNPUL2 TRIM49B	1.31e-03	95	159	5	PS50188
Domain	TIMP-like_OB-fold	C4A C4B C5	1.36e-03	26	159	3	IPR008993
Domain	RBD	RAF1 ARAF	1.47e-03	7	159	2	SM00455
Domain	RBD_dom	RAF1 ARAF	1.47e-03	7	159	2	IPR003116
Domain	RBD	RAF1 ARAF	1.47e-03	7	159	2	PS50898
Domain	HEAT	STK36 ATR SCYL1 PPP2R1A	1.50e-03	58	159	4	IPR000357
Domain	MacrogloblnA2_thiol-ester-bond	C4A C4B	1.95e-03	8	159	2	IPR019565
Domain	Thiol-ester_cl	C4A C4B	1.95e-03	8	159	2	PF10569
Domain	MacrogloblnA2_CS	C4A C4B	1.95e-03	8	159	2	IPR019742
Domain	A2M_N_2	C4A C5	1.95e-03	8	159	2	SM01359
Domain	-	C4A C5	1.95e-03	8	159	2	2.60.40.690
Domain	A2M_recep	C4A C5	1.95e-03	8	159	2	SM01361
Domain	A2M	C4A C5	1.95e-03	8	159	2	SM01360
Domain	ARM-like	STK36 ATR SCYL1 HUWE1 TRIP12 PPP2R1A PLAA PPP6R3	2.23e-03	270	159	8	IPR011989
Domain	ENTH	HIP1 HIP1R	2.49e-03	9	159	2	PS50942
Domain	ENTH	HIP1 HIP1R	2.49e-03	9	159	2	SM00273
Domain	ENTH	HIP1 HIP1R	3.10e-03	10	159	2	IPR013809
Domain	IL-1_rcpt_fam	LAG3 IL18RAP	3.77e-03	11	159	2	IPR015621
Domain	tRNA_anti-codon	RMI1 RPA1	4.49e-03	12	159	2	PF01336
Domain	WWE	HUWE1 TRIP12	4.49e-03	12	159	2	PF02825
Domain	WWE-dom	HUWE1 TRIP12	4.49e-03	12	159	2	IPR004170
Domain	NA-bd_OB_tRNA	RMI1 RPA1	4.49e-03	12	159	2	IPR004365
Domain	WWE	HUWE1 TRIP12	4.49e-03	12	159	2	PS50918
Pathway	REACTOME_ACTIVATION_OF_C3_AND_C5	C4A C4B C5	1.95e-05	7	118	3	MM14685
Pathway	REACTOME_ACTIVATION_OF_C3_AND_C5	C4A C4B C5	3.11e-05	8	118	3	M27031
Pathway	BIOCARTA_LECTIN_PATHWAY	C4A C4B C5	8.98e-05	11	118	3	MM1430
Pathway	BIOCARTA_CLASSIC_PATHWAY	C4A C4B C5	1.19e-04	12	118	3	MM1368
Pathway	WP_ESTROGEN_RECEPTOR_PATHWAY	CYP1A1 CYP1A2 ACOX1	1.54e-04	13	118	3	M39496
Pathway	BIOCARTA_LECTIN_PATHWAY	C4A C4B C5	1.54e-04	13	118	3	M4732
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	RAF1 KIAA0930 INTS12 RAPH1 CEP192 STIL SPECC1 TRIP12 ARAF SHKBP1 ISCU ARFGAP1 CGN MAP3K10 FAM83G MACF1 AKAP13 IRS2 MTCL1 BICC1	6.35e-09	861	166	20	36931259
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	HNRNPDL RAF1 STK36 KIAA0930 HSPA4L PAPSS2 ARAF HNRNPL MEN1 DERA SORT1 SLC30A7 CDAN1 PPP2R1A GET4 IGHA2 KCTD5 PEBP1 PES1 CGN FAM83G AKAP13 IRS2	5.36e-08	1284	166	23	17353931
Pubmed	Mouse complement component C4 is devoid of classical pathway C5 convertase subunit activity.	C4A C4B C5	1.07e-07	3	166	3	8649451
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	HNRNPDL DMTF1 TICRR RHBDF1 SLFN12 ARHGEF18 CEP192 HUWE1 TRIP12 ASH2L AKAP12 KNOP1 MEN1 PLAA ARFGAP1 LRP2 CRYBG1 MACF1 RPA1 BICC1	2.69e-07	1084	166	20	11544199
Pubmed	Impaired mast cell-dependent natural immunity in complement C3-deficient mice.	C4A C4B C5	4.26e-07	4	166	3	9367154
Pubmed	H-2 S region determined polymorphic variants of the C4, Slp, C2, and B complement proteins: a compilation.	MBP C4A C4B	4.26e-07	4	166	3	6190740
Pubmed	Phylogeny of the C3/C4/C5 complement-component gene family indicates that C5 diverged first.	C4A C4B C5	4.26e-07	4	166	3	8015436
Pubmed	The Crystal Structure of the Ubiquitin-like Domain of Ribosome Assembly Factor Ytm1 and Characterization of Its Interaction with the AAA-ATPase Midasin.	PES1 NLE1 WDR12	1.06e-06	5	166	3	26601951
Pubmed	Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia.	C4A C4B C5	1.06e-06	5	166	3	15192652
Pubmed	Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies.	C4A C4B C5	1.06e-06	5	166	3	17200182
Pubmed	Predominant role for C5b-9 in renal ischemia/reperfusion injury.	C4A C4B C5	1.06e-06	5	166	3	10811844
Pubmed	Raf kinase inhibitory protein regulates Raf-1 but not B-Raf kinase activation.	RAF1 MBP PEBP1	1.06e-06	5	166	3	15886202
Pubmed	Intranasal peptide-induced tolerance and linked suppression: consequences of complement deficiency.	C4A C4B C5	1.06e-06	5	166	3	25039245
Pubmed	Formation of high affinity C5 convertase of the classical pathway of complement.	C4A C4B C5	1.06e-06	5	166	3	12878586
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	HNRNPDL WDR7 SCYL1 MUC16 CEP192 HUWE1 TRIP12 AKAP12 DMXL1 KNOP1 VPS52 PEBP1 ARFGAP1 VPS13A TNRC6A ZFR	1.11e-06	777	166	16	35844135
Pubmed	Complement activation via alternative pathway is critical in the development of laser-induced choroidal neovascularization: role of factor B and factor H.	C4A C4B C5	2.11e-06	6	166	3	16849499
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	HNRNPDL RAF1 PDSS2 HK2 HSPA4L SYNE1 SCYL1 HUWE1 ARAF HNRNPL VPS52 GET4 HNRNPUL2 PEBP1 ISCU VPS13A LRP2 ZFR WDR12 MINDY4 RPA1 RAB29	2.87e-06	1496	166	22	32877691
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	RAF1 RC3H2 HK2 ATR ARHGAP23 PAPSS2 ASH2L ARAF HNRNPUL2 DROSHA AKAP13 C4A C4B SORL1	3.21e-06	650	166	14	38777146
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	RAPH1 ZNF185 CEP192 STIL ARAF MEN1 VPS52 PEBP1 ARFGAP1 CGN TNRC6A LRP2 FAM83G MINDY4 ALDH7A1 PPP6R3	3.67e-06	853	166	16	28718761
Pubmed	Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome.	C4A C4B C5	3.69e-06	7	166	3	14660741
Pubmed	Tagging genes with cassette-exchange sites.	WDR7 TRIP12 ASH2L DMXL1 PLAA DROSHA MACF1 AKAP13 KAT6B PPP6R3	5.30e-06	335	166	10	15741177
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	HNRNPDL FAM114A1 GPR19 INTS12 RAPH1 HSPA4L SYNE1 RAB22A DNAH2 FAM114A2 MSL1 TRIP12 KNOP1 MEN1 PES1 VPS13A NLE1 MACF1 ZFR POTEJ ATP1A2	5.71e-06	1442	166	21	35575683
Pubmed	C3 opsonization regulates endocytic handling of apoptotic cells resulting in enhanced T-cell responses to cargo-derived antigens.	C4A C4B C5	5.88e-06	8	166	3	24474777
Pubmed	The role of complement in cryoglobulin-induced immune complex glomerulonephritis.	C4A C4B C5	5.88e-06	8	166	3	16272350
Pubmed	Synergy between the classical and alternative pathways of complement is essential for conferring effective protection against the pandemic influenza A(H1N1) 2009 virus infection.	C4A C4B C5	5.88e-06	8	166	3	28301559
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	STK36 KIAA0930 HIP1 RHBDF1 SEMA7A MFHAS1 HIP1R CEP192 HUWE1 RALGAPA2 GET4 CLN3 NLE1 AKAP13 IRS2 LTK HAS3 PRDM16	6.25e-06	1105	166	18	35748872
Pubmed	Lineage-specific biology revealed by a finished genome assembly of the mouse.	TRIM49 TRIM49C MACF1 TRIM49B PRDM16	6.69e-06	55	166	5	19468303
Pubmed	Cullin 1 (CUL1) Promotes Primary Ciliogenesis through the Induction of Ubiquitin-Proteasome-Dependent Dvl2 Degradation.	RAF1 SYNE1 STIL ACTL7B BMP1 ISCU MACF1	9.00e-06	152	166	7	34299191
Pubmed	Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer.	RAF1 KIAA0930 ARAF ISCU CGN IRS2	9.96e-06	102	166	6	15778465
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	HIP1 RHBDF1 INTS12 SYNE1 RAB22A HIP1R MSL1 SPECC1 ASH2L ARAF KNOP1 MEN1 SHKBP1 SLC30A7 DROSHA PES1 TNRC6A CRYBG1 MACF1 WDR12 PPP6R3	1.01e-05	1497	166	21	31527615
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	RAF1 KIAA0930 CEP192 ARAF SHKBP1 PPP2R1A CGN TNRC6A IRS2 MTCL1 PPP6R3	1.08e-05	446	166	11	24255178
Pubmed	A protein interaction landscape of breast cancer.	HNRNPDL RAF1 HK2 HSPA4L ZNF185 HIP1R SPECC1 ARAF PLAA HNRNPUL2 MACF1 RPA1 PPP6R3	1.23e-05	634	166	13	34591612
Pubmed	Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma.	ZNF185 HIP1R LAMA3 TRIP12 HNRNPL HNRNPUL2 PEBP1 PES1 TNRC6A ZFR C4A C5 RPA1 FYN	1.23e-05	732	166	14	34732716
Pubmed	Complement Inhibitor CRIg/FH Ameliorates Renal Ischemia Reperfusion Injury via Activation of PI3K/AKT Signaling.	C4A C4B C5	1.25e-05	10	166	3	30429287
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	COL12A1 SPECC1 TRIP12 AKAP12 DERA SLC30A7 PPP2R1A PES1 ARFGAP1 NLE1 MACF1 AKAP13 ZFR WDR12 MTCL1 RPA1 FYN ALDH7A1 PPP6R3	1.52e-05	1297	166	19	33545068
Pubmed	K63 ubiquitylation triggers proteasomal degradation by seeding branched ubiquitin chains.	HNRNPDL HSPA4L HUWE1 PPP2R1A PPP6R3	1.53e-05	65	166	5	29378950
Pubmed	The gene map of the Norway rat (Rattus norvegicus) and comparative mapping with mouse and man.	RAF1 CYP1A1 CYP1A2 C4A C4B	1.65e-05	66	166	5	1889815
Pubmed	PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.	ATR HUWE1 SPECC1 ARAF HNRNPL SHKBP1 PPP2R1A DROSHA CGN C4A C4B	2.02e-05	477	166	11	31300519
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	FAM114A1 HK2 HSPA4L SCYL1 HUWE1 PAPSS2 AKAP12 DERA CDAN1 PPP2R1A GET4 PLAA HNRNPUL2 PES1 ARFGAP1 MACF1 WDR12 RPA1 ALDH7A1 PPP6R3	2.22e-05	1455	166	20	22863883
Pubmed	SERBP1 Promotes Stress Granule Clearance by Regulating 26S Proteasome Activity and G3BP1 Ubiquitination and Protects Male Germ Cells from Thermostimuli Damage.	HIP1 LDHAL6A HSPA4L HUWE1 TRIP12 AKAP12 SGPP1 PPP2R1A GET4 PLAA PES1 ARFGAP1 ATP1A2 RPA1 PPP6R3	2.23e-05	878	166	15	37223481
Pubmed	Copy number analysis of complement C4A, C4B and C4A silencing mutation by real-time quantitative polymerase chain reaction.	C4A C4B	2.26e-05	2	166	2	22737222
Pubmed	Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection.	C4A C4B	2.26e-05	2	166	2	16565498
Pubmed	Complete deficiencies of complement C4A and C4B including 2-bp insertion in codon 1213 are genetic risk factors of systemic lupus erythematosus in Thai populations.	C4A C4B	2.26e-05	2	166	2	15998580
Pubmed	High-throughput analysis of the C4 polymorphism by a combination of MLPA and isotype-specific ELISA's.	C4A C4B	2.26e-05	2	166	2	19062096
Pubmed	Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice.	C4A C4B	2.26e-05	2	166	2	19933335
Pubmed	Methylation differences in the murine P1450 and P3450 genes in wild-type and mutant hepatoma cell culture.	CYP1A1 CYP1A2	2.26e-05	2	166	2	2425809
Pubmed	Hip1-related mutant mice grow and develop normally but have accelerated spinal abnormalities and dwarfism in the absence of HIP1.	HIP1 HIP1R	2.26e-05	2	166	2	15121852
Pubmed	Degenerative phenotypes caused by the combined deficiency of murine HIP1 and HIP1r are rescued by human HIP1.	HIP1 HIP1R	2.26e-05	2	166	2	17452370
Pubmed	Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4.	C4A C4B	2.26e-05	2	166	2	2459207
Pubmed	Antigen-induced B cell apoptosis is independent of complement C4.	C4A C4B	2.26e-05	2	166	2	17645767
Pubmed	Anti-DNA autoreactivity in C4-deficient mice.	C4A C4B	2.26e-05	2	166	2	12207352
Pubmed	Mammalian Ras interacts directly with the serine/threonine kinase Raf.	RAF1 ARAF	2.26e-05	2	166	2	8334704
Pubmed	Cloning and isolation of human cytochrome P-450 cDNAs homologous to dioxin-inducible rabbit mRNAs encoding P-450 4 and P-450 6.	CYP1A1 CYP1A2	2.26e-05	2	166	2	3000715
Pubmed	Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients.	C4A C4B	2.26e-05	2	166	2	27758680
Pubmed	Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations.	C4A C4B	2.26e-05	2	166	2	22387014
Pubmed	The FAM114A proteins are adaptors for the recycling of Golgi enzymes.	FAM114A1 FAM114A2	2.26e-05	2	166	2	39129673
Pubmed	Characterization of human CYP1A1/1A2 induction by DNA microarray and alpha-naphthoflavone.	CYP1A1 CYP1A2	2.26e-05	2	166	2	12147246
Pubmed	Riluzole metabolism and CYP1A1/2 polymorphisms in patients with ALS.	CYP1A1 CYP1A2	2.26e-05	2	166	2	17852022
Pubmed	Cyp1a2 protects against reactive oxygen production in mouse liver microsomes.	CYP1A1 CYP1A2	2.26e-05	2	166	2	14980704
Pubmed	Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner.	C4A C4B	2.26e-05	2	166	2	23749435
Pubmed	Non-proteolytic ubiquitination of Hexokinase 2 by HectH9 controls tumor metabolism and cancer stem cell expansion.	HK2 HUWE1	2.26e-05	2	166	2	31201299
Pubmed	Copy number variations of complement component C4 are associated with Behçet's disease but not with ankylosing spondylitis associated with acute anterior uveitis.	C4A C4B	2.26e-05	2	166	2	23918728
Pubmed	Loss of RAF kinase inhibitor protein is a somatic event in the pathogenesis of therapy-related acute myeloid leukemias with C-RAF germline mutations.	RAF1 PEBP1	2.26e-05	2	166	2	19357705
Pubmed	Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein.	C4A C4B	2.26e-05	2	166	2	3037333
Pubmed	Evidence of a role for C4 in modulating interstitial inflammation in experimental glomerulonephritis.	C4A C4B	2.26e-05	2	166	2	11726230
Pubmed	Quantitative variations in the expression of the mouse serum antigen Ss and its sex-limited allotype Slp.	C4A C4B	2.26e-05	2	166	2	4216347
Pubmed	Sequence determination of the thiolester site of the fourth component of human complement.	C4A C4B	2.26e-05	2	166	2	6950384
Pubmed	A-Raf and C-Raf differentially regulate mechanobiological response of osteoblasts to guide mechanical stress-induced differentiation.	RAF1 ARAF	2.26e-05	2	166	2	27240957
Pubmed	Novel treatment option for MUC16-positive malignancies with the targeted TRAIL-based fusion protein Meso-TR3.	TNFSF10 MUC16	2.26e-05	2	166	2	24447304
Pubmed	Visual demonstration of the organization of the human complement C4 and 21-hydroxylase genes by high-resolution fluorescence in situ hybridization.	C4A C4B	2.26e-05	2	166	2	8660986
Pubmed	Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain.	C4A C4B	2.26e-05	2	166	2	8428773
Pubmed	Immunocytochemical study of cytochrome P450 (1A1/1A2) induction in murine ocular tissues.	CYP1A1 CYP1A2	2.26e-05	2	166	2	7781742
Pubmed	Organization of the CYP1A cluster on human chromosome 15: implications for gene regulation.	CYP1A1 CYP1A2	2.26e-05	2	166	2	11207026
Pubmed	Tissue-specific expression of the mouse dioxin-inducible P(1)450 and P(3)450 genes: differential transcriptional activation and mRNA stability in liver and extrahepatic tissues.	CYP1A1 CYP1A2	2.26e-05	2	166	2	3785172
Pubmed	Assignment of dioxin-inducible cytochrome P-450 gene family to Chinese hamster chromosome 4.	CYP1A1 CYP1A2	2.26e-05	2	166	2	3860967
Pubmed	Complement C4 deficiency--a plausible risk factor for non-tuberculous mycobacteria (NTM) infection in apparently immunocompetent patients.	C4A C4B	2.26e-05	2	166	2	24638111
Pubmed	Transcriptional repression of C4 complement by hepatitis C virus proteins.	C4A C4B	2.26e-05	2	166	2	21345967
Pubmed	Search for an association between the human CYP1A2 genotype and CYP1A2 metabolic phenotype.	CYP1A1 CYP1A2	2.26e-05	2	166	2	16609368
Pubmed	Cyp1a1(-/-) male mice: protection against high-dose TCDD-induced lethality and wasting syndrome, and resistance to intrahepatocyte lipid accumulation and uroporphyria.	CYP1A1 CYP1A2	2.26e-05	2	166	2	15094312
Pubmed	Restriction fragment analysis of H-2 recombinant mouse strains with crossovers between E alpha and C4 genes.	C4A C4B	2.26e-05	2	166	2	2572548
Pubmed	The complement component C4 of mammals.	C4A C4B	2.26e-05	2	166	2	2302180
Pubmed	Gene CNVs and protein levels of complement C4A and C4B as novel biomarkers for partial disease remissions in new-onset type 1 diabetes patients.	C4A C4B	2.26e-05	2	166	2	22151770
Pubmed	C4d-positive chronic rejection: a frequent entity with a poor outcome.	C4A C4B	2.26e-05	2	166	2	18091514
Pubmed	Comprehensive approach to study complement C4 in systemic lupus erythematosus: Gene polymorphisms, protein levels and functional activity.	C4A C4B	2.26e-05	2	166	2	29080553
Pubmed	Genes for murine fourth complement component (C4) and sex-limited protein (Slp) identified by hybridization to C4- and Slp-specific cDNA.	C4A C4B	2.26e-05	2	166	2	6589636
Pubmed	C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production.	C4A C4B	2.26e-05	2	166	2	25339671
Pubmed	A study of association of the complement C4 mutations with systemic lupus erythematosus in the Malaysian population.	C4A C4B	2.26e-05	2	166	2	17728371
Pubmed	CYP1A1 and CYP1A2 expression: comparing 'humanized' mouse lines and wild-type mice; comparing human and mouse hepatoma-derived cell lines.	CYP1A1 CYP1A2	2.26e-05	2	166	2	19285097
Pubmed	Structure and organization of the C4 genes.	C4A C4B	2.26e-05	2	166	2	6149580
Pubmed	Sequence heterogeneity of murine complementary DNA clones related to the C4 and C4-Slp isoforms of the fourth complement component.	C4A C4B	2.26e-05	2	166	2	6149581
Pubmed	The follicular dendritic cell restricted epitope, FDC-M2, is complement C4; localization of immune complexes in mouse tissues.	C4A C4B	2.26e-05	2	166	2	12115608
Pubmed	Biochemistry and biology of anaphylatoxins.	C4A C4B	2.26e-05	2	166	2	3542363
Pubmed	[Association of polymorph variants of CYP1A2 and CYP1A1 genes with reproductive and thyroid diseases in female workers of petrochemical industry].	CYP1A1 CYP1A2	2.26e-05	2	166	2	22855999
Pubmed	C4 from C4-high and C4-low mouse strains have identical sequences in the region corresponding to the isotype-specific segment of human C4.	C4A C4B	2.26e-05	2	166	2	2387317
Pubmed	ATR prohibits replication catastrophe by preventing global exhaustion of RPA.	ATR RPA1	2.26e-05	2	166	2	24267891
Pubmed	Differential regulation of expression of hepatic and pulmonary cytochrome P4501A enzymes by 3-methylcholanthrene in mice lacking the CYP1A2 gene.	CYP1A1 CYP1A2	2.26e-05	2	166	2	12438513
Pubmed	Identification of the size and antigenic determinants of the human C4 gene by a polymerase chain-reaction-based amplification method.	C4A C4B	2.26e-05	2	166	2	16908004
Pubmed	Structural studies on the murine fourth component of complement (C4). IV. Demonstration that C4 and Slp are encoded by separate loci.	C4A C4B	2.26e-05	2	166	2	7365238
Pubmed	Interaction between the labile binding sites of the fourth (C4) and fifth (C5) human complement proteins and erythrocyte cell membranes.	C4A C4B	2.26e-05	2	166	2	7391573
Pubmed	Peritubular capillary C4d deposition in lupus nephritis different from antibody-mediated renal rejection.	C4A C4B	2.26e-05	2	166	2	17971360
Interaction	PWP1 interactions	RAF1 RC3H2 HUWE1 ASH2L MEN1 PES1 NLE1 WDR12 LTK PPP6R3	3.78e-06	198	158	10	int:PWP1
Interaction	YWHAG interactions	RAF1 TICRR RC3H2 KIAA0930 RAPH1 ARHGAP23 CEP192 HUWE1 SPECC1 TRIP12 ARAF SHKBP1 PTPDC1 PPP2R1A ISCU CGN MAP3K10 FAM83G MACF1 AKAP13 IRS2 MTCL1 RPA1 BICC1 ALDH7A1 PPP6R3	4.52e-06	1248	158	26	int:YWHAG
Interaction	MAP2K3 interactions	RAF1 HSPA4L HIP1R HUWE1 TRIP12 ARAF AKAP12 HNRNPL PPP2R1A AKAP13 RPA1	4.83e-06	251	158	11	int:MAP2K3
Interaction	YWHAH interactions	RAF1 TICRR KIAA0930 INTS12 CEP192 HUWE1 STIL SPECC1 TRIP12 ARAF SHKBP1 PTPDC1 ISCU ARFGAP1 CGN MAP3K10 FAM83G MACF1 AKAP13 IRS2 MTCL1 RPA1 BICC1 ALDH7A1	5.26e-06	1102	158	24	int:YWHAH
Interaction	ARL2 interactions	HNRNPDL RAF1 ACOX1 CEP192 PTPDC1 PPP2R1A PES1 RPA1	9.67e-06	132	158	8	int:ARL2
Interaction	PCNP interactions	HNRNPDL RAF1 DCAF15 HUWE1 PAPSS2 MEN1 RPA1	1.06e-05	96	158	7	int:PCNP
Interaction	YWHAZ interactions	RAF1 TICRR KIAA0930 RAPH1 WDR7 MBP HIP1R ARHGEF18 CEP192 HUWE1 SPECC1 TRIP12 ARAF HNRNPL PTPDC1 PPP2R1A CSF2RB IGHA2 ISCU CGN MAP3K10 FAM83G MACF1 AKAP13 IRS2 RPA1	1.21e-05	1319	158	26	int:YWHAZ
Interaction	MKI67 interactions	RAF1 STK36 TICRR ATR DNAH2 ARHGEF18 ASH2L KNOP1 MEN1 RMI1 PPP2R1A VPS52 HNRNPUL2 PES1 NLE1 AKAP13 RPA1	1.38e-05	648	158	17	int:MKI67
Interaction	YWHAB interactions	RAF1 TICRR RC3H2 KIAA0930 GPR15 ARHGAP23 CEP192 SPECC1 TRIP12 ARAF SHKBP1 PTPDC1 PPP2R1A PEBP1 CGN MAP3K10 FAM83G MACF1 AKAP13 IRS2 MTCL1 RPA1	1.44e-05	1014	158	22	int:YWHAB
Interaction	BOP1 interactions	RAF1 RC3H2 HIP1R HUWE1 MEN1 PES1 NLE1 WDR12 RPA1	2.04e-05	191	158	9	int:BOP1
Interaction	MARK3 interactions	HNRNPDL RAF1 CEP192 HNRNPL PPP2R1A MANSC1 MACF1 AKAP13 MTCL1 RPA1	2.52e-05	246	158	10	int:MARK3
Interaction	ZCCHC8 interactions	RC3H2 ASH2L HNRNPL MEN1 PPP2R1A HNRNPUL2 DROSHA RPA1	2.96e-05	154	158	8	int:ZCCHC8
Interaction	ARHGEF18 interactions	ARHGAP23 ARHGEF18 HUWE1 HNRNPL AKAP13	4.01e-05	49	158	5	int:ARHGEF18
Interaction	ADCY6 interactions	RAF1 SLC39A4 MANSC1 SPAG16 CLEC2B	6.45e-05	54	158	5	int:ADCY6
Interaction	RAPGEFL1 interactions	ARHGAP23 ARHGEF18 RALGAPA2 AKAP13	7.41e-05	29	158	4	int:RAPGEFL1
GeneFamily	WD repeat domain containing	WDR7 NBEAL1 SEC31B DMXL1 SHKBP1 WDR38 PLAA NLE1 WDR12 WDR86 SPAG16	2.67e-07	262	102	11	362
GeneFamily	C3 and PZP like, alpha-2-macroglobulin domain containing	C4A C4B C5	1.43e-05	9	102	3	1234
GeneFamily	Cytochrome P450 family 1	CYP1A1 CYP1A2	1.88e-04	4	102	2	1000
GeneFamily	Mitogen-activated protein kinase kinase kinases\|RAF family	RAF1 ARAF	3.12e-04	5	102	2	1157
GeneFamily	Mitogen-activated protein kinase kinase kinases\|RAF family	RAF1 ARAF MAP3K10	3.24e-04	24	102	3	654
GeneFamily	Complement system\|Sushi domain containing	C4A C4B C5	1.09e-03	36	102	3	492
GeneFamily	Glycosyltransferase family 6\|Blood group antigens	SEMA7A C4A C4B	1.18e-03	37	102	3	454
Coexpression	GSE3982_MAST_CELL_VS_NKCELL_DN	CYP1A2 UNC5B ZNF185 DNAH2 LTB4R2 IL18RAP CHST4 ARFGAP1 FYN CLEC2B	5.40e-07	199	164	10	M5452
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZNF185 MUC16 BMP1 CHST4 LRP2 C4B WDR86 BICC1	3.94e-07	181	165	8	330d4322f4c4373f706273c1f4e218b59051b7fd
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZNF185 MUC16 BMP1 CHST4 LRP2 C4B WDR86 BICC1	3.94e-07	181	165	8	3f4d5d79c1286614514b0e8134079d6128a2a23e
ToppCell	T_cells-CTLs\|World / Immune cells in Kidney/Urine in Lupus Nephritis	SYNE1 MBP LAG3 MACF1 RAB29 FYN PRDM16 PIK3R5	7.47e-07	197	165	8	2de34e20915a247bee75aa40495e23c20bb23e18
ToppCell	facs-Marrow-T-cells-24m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAG3 LAMA3 PAPSS2 IL18RAP CSF2RB OTOGL ALOX15B	2.02e-06	157	165	7	ed9c9feefc06c9536c03bedbc3397a2ee492a78e
ToppCell	facs-Marrow-T-cells-24m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAG3 LAMA3 PAPSS2 IL18RAP CSF2RB OTOGL ALOX15B	2.02e-06	157	165	7	fddcb24776b9f86e000208bae54541b15b2adefd
ToppCell	droplet-Heart-HEART_(ALL_4:4:4:1:1)\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGEF18 STIL BCO2 CHST4 LRP2 C4A	2.50e-06	104	165	6	fdf4599de8cd4ccf1bd7ede4e7af63d69c108b43
ToppCell	droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGEF18 STIL BCO2 CHST4 LRP2 C4A	2.50e-06	104	165	6	a3d061170fe49d023ac31dbaeb2b5d2347988078
ToppCell	facs-Marrow-T_cells-18m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAG3 PAPSS2 IL18RAP CSF2RB ST8SIA6 OTOGL ALOX15B	2.92e-06	166	165	7	c22b0f3bf990d94b615a3aacee5de548da2db628
ToppCell	facs-Marrow-T_cells-18m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAG3 PAPSS2 IL18RAP CSF2RB ST8SIA6 OTOGL ALOX15B	2.92e-06	166	165	7	0975fc165bcc7e85f053d9d0244fffe407c23571
ToppCell	E18.5-Immune-Immune_Myeloid-Granulocytic-Basophil\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TICRR GPR19 SYNE1 ARHGEF18 IL18RAP CSF2RB ALOX15B	3.29e-06	169	165	7	b23d0aaa2da333b9c69a7aee862d5a5d2a1bf79b
ToppCell	E18.5-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TICRR GPR19 SYNE1 ARHGEF18 IL18RAP CSF2RB ALOX15B	3.29e-06	169	165	7	83d1bcf33872b01ea9614f608a3e4ab30df25c7e
ToppCell	facs-Marrow-T-cells-3m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAG3 PAPSS2 IL18RAP CSF2RB ST8SIA6 FYN ALOX15B	4.63e-06	178	165	7	41745a589567ca5ea6d06331f4c8da03595b5f5c
ToppCell	facs-Marrow-T-cells-3m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAG3 PAPSS2 IL18RAP CSF2RB ST8SIA6 FYN ALOX15B	4.63e-06	178	165	7	eb940dd64c973f68bcaad6069d3bd56383329db5
ToppCell	BAL-Control-cDC_8\|Control / Compartment, Disease Groups and Clusters	HK2 ZNF185 SLC39A4 AKAP12 KNOP1 BMP1 MAP3K10	5.16e-06	181	165	7	f370161afef2ec827a7b194c06abb9ac1a507cbb
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL12A1 RAPH1 SYNE1 SPECC1 AKAP12 WDR86 ATP1A2	6.40e-06	187	165	7	15d6e158562d7d85af3ceaf955439b379c8fce81
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL12A1 RAPH1 SYNE1 SPECC1 AKAP12 WDR86 ATP1A2	6.40e-06	187	165	7	f62074b631fd45ad299c69d71b09267b04d656ee
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL12A1 RAPH1 SYNE1 SPECC1 AKAP12 WDR86 ATP1A2	6.62e-06	188	165	7	32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-MAIT\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LAG3 IL18RAP WDR86 LTK FYN PIK3R5 SORL1	6.86e-06	189	165	7	159b0979c93b7d98aaeeb43fba5983a9f67b9c9d
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	HIP1R LAMA3 LRP2 C5 HAS3 PRDM16 SORL1	6.86e-06	189	165	7	5d9da836ce4308b8458bb3be3871a0aca734b6cd
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	HIP1R LAMA3 CGN LRP2 HAS3 PRDM16 SORL1	7.10e-06	190	165	7	625c08a0e5227efc46daa512fd579c3938ff76c7
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	MBP AKAP12 MACF1 AKAP13 MTCL1 FYN PIK3R5	7.60e-06	192	165	7	8b86db2ebe0199fee0e9800566a619a24bfdeed5
ToppCell	mLN-T_cell-Th1\|mLN / Region, Cell class and subclass	CATIP LAG3 IL18RAP CFAP126 LTK FYN CLEC2B	9.28e-06	198	165	7	7627b7c3a248da2bd5e1e6f7c226e5fd0bc92113
ToppCell	mLN-(1)_T_cell-(12)_Th1\|mLN / shred on region, Cell_type, and subtype	CATIP LAG3 IL18RAP CFAP126 LTK FYN CLEC2B	9.28e-06	198	165	7	1fe8257233232b264b9ca630c2d92c509a195353
ToppCell	COVID_non-vent-Lymphocytic-ILC\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	SYNE1 MBP IL18RAP MACF1 RAB29 FYN SORL1	9.59e-06	199	165	7	df4f7d5be099e3e6054f3b812ccf70251664e4c0
ToppCell	COVID_non-vent-Lymphocytic-ILC-NK_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	SYNE1 MBP IL18RAP MACF1 RAB29 FYN SORL1	9.59e-06	199	165	7	ed35d747f11f6ea6a5cb7061057f0a98d9e0db99
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SYNE1 MSL1 RALGAPA2 IL18RAP MANSC1 CSF2RB SORL1	9.91e-06	200	165	7	6beabd5bad042d4d65c89c2f537c7376230f7c08
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SYNE1 MSL1 RALGAPA2 IL18RAP MANSC1 CSF2RB SORL1	9.91e-06	200	165	7	026495aa7f1e7528a01d9199475cfc393677fc60
ToppCell	(01)_IL1RL1+\|World / shred by cell type by condition	COL12A1 LAMA3 TENM2 AKAP12 BMP1 HAS3 ALOX15B	9.91e-06	200	165	7	501420901bf3ec1b050e0d14596a9f9f3fdfc928
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP23 UNC5B SYNE1 LTK ATP1A2 FYN	2.85e-05	159	165	6	d3f81ba22160568ccaa6d2b04ebfd30630f9a6db
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RAPH1 UNC5B SYNE1 AKAP12 WDR86 ATP1A2	2.85e-05	159	165	6	5ca96db4281abb5f646150ccf36adc66ab201c78
ToppCell	Ciliated_cells-B-Donor_05\|World / lung cells shred on cell class, cell subclass, sample id	CATIP DNAH2 MUC16 WDR38 CFAP126 C4A	3.17e-05	162	165	6	5319603f7ba3f48126dcf2ba9ae604be11bf2577
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL12A1 HK2 AKAP12 LRP2 MTCL1 BICC1	3.39e-05	164	165	6	382e42701779d12a7948690b3be72d06dd75c8b4
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	LAG3 XPNPEP2 IL18RAP CGN LTK FYN	3.51e-05	165	165	6	5e7ee76f3dcddbd1b560bacd043f9001b0c18b5f
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Radial_glial-RGCs_early_2\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	RHBDF1 PAPSS2 WDR38 CFAP126 DMRT3 TRIM49B	3.51e-05	165	165	6	e460e03992781073cd836a655f15dda3157cea55
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZNF185 MUC16 CHST4 LRP2 C4B BICC1	3.75e-05	167	165	6	c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZNF185 MUC16 CHST4 LRP2 C4B BICC1	3.75e-05	167	165	6	351f8de1fbdf742ac74f9099b254d515ab539bb2
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(more_DN)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP23 SLFN12 STIL PTPDC1 NLE1 C4A	3.88e-05	168	165	6	b9db0b1e4fe54a1fe79530d15d206155a1bfac39
ToppCell	368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	RHBDF1 SYNE1 MBP SEC31B IRS2 ALOX15B	4.15e-05	170	165	6	f0b0d2d0402de3ed7322284a599646db43475761
ToppCell	368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	RHBDF1 SYNE1 MBP SEC31B IRS2 ALOX15B	4.15e-05	170	165	6	054360a3b05f5e41221c98b122d241b1affad26a
ToppCell	10x5'-Lung-Lymphocytic_Invariant-Inducer-like-MAIT\|Lung / Manually curated celltypes from each tissue	LAG3 IL18RAP WDR38 WDR86 LTK FYN	4.87e-05	175	165	6	f6663e5a9c87e27f3459a6481768b03aff7d0855
ToppCell	3'_v3-blood-Mast-Mast_cells\|blood / Manually curated celltypes from each tissue	SEMA7A ACOX1 AKAP12 CSF2RB VSIG10L MTCL1	5.03e-05	176	165	6	b9da3deaf62622d47eb30b6be7548253eee95597
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.4\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HNRNPDL NBEAL1 LAG3 CRYBG1 AKAP13 FYN	5.03e-05	176	165	6	ce85a13e10cf37f5cf38ca8b0bac6701b6d00ffd
ToppCell	3'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CATIP TNFSF10 UNC5B F8 CFAP126 CSF2RB	5.19e-05	177	165	6	d6596a0b6fd146fefc27717c1a7dbaa3774cc644
ToppCell	10x5'-Lung-Lymphocytic_Invariant-Inducer-like\|Lung / Manually curated celltypes from each tissue	LAG3 IL18RAP WDR38 WDR86 LTK FYN	5.36e-05	178	165	6	bb5dc22f6bcde1ce29598ae4e839e98a7caa07b6
ToppCell	P28-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MBP MUC16 CHST4 LRP2 WDR86 BICC1	5.36e-05	178	165	6	1e05bc26591fea16e29bcfc5f538dda1dc427f05
ToppCell	droplet-Bladder-nan-24m-Epithelial-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL18RAP ACTL7B C4B LTK ATP1A2 SPAG16	5.52e-05	179	165	6	dfd9d29281510d32f1a2e8336d2e58ef496cfd1d
ToppCell	normal-na-Lymphocytic_NK-T_mait-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	LAG3 IL18RAP MACF1 LTK FYN CLEC2B	5.70e-05	180	165	6	e66a8a61b3576ac37de7c559d16d4ed4f7a2fc78
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-Ependyma\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF185 SLC39A4 CFAP126 DMRT3 WDR86 SPAG16	5.70e-05	180	165	6	729f0d7af573c7796d8e28e6eec3af2fc0bd33a2
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-ependymal_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF185 SLC39A4 CFAP126 DMRT3 WDR86 SPAG16	5.70e-05	180	165	6	9ef79a7c60227e352ac166c7274adb31f585f5ca
ToppCell	RA-13._Vascular_Smooth_Muscle\|RA / Chamber and Cluster_Paper	HIP1 NBEAL1 LAMA3 SPECC1 SORT1 PRDM16	6.24e-05	183	165	6	818fd886e0188091310825f9145fa53328f2c979
ToppCell	PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	LAMA3 LRP2 C5 HAS3 PRDM16 SORL1	6.44e-05	184	165	6	fa4915b0498f3069fd5ef497286445528f75187e
ToppCell	Control-T_cells-NK_cells\|Control / group, cell type (main and fine annotations)	MBP IL18RAP FYN PIK3R5 CLEC2B SORL1	6.63e-05	185	165	6	755c0998c729f462399f1d5e88adf4bfae31be30
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	LAMA3 MUC16 TENM4 OTOGL IRS2 PRDM16	6.83e-05	186	165	6	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	facs-Heart-LA-24m-Myeloid-macrophage\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC39A4 TENM2 KYAT1 CHST4 CGN MTCL1	6.83e-05	186	165	6	246503fd4e6ae24041c606b069eb5fb313e60f73
ToppCell	facs-Heart-LA-24m-Myeloid-macrophage\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC39A4 TENM2 KYAT1 CHST4 CGN MTCL1	6.83e-05	186	165	6	ef93ac469eb4f63db036f14b442c1503b8c6de38
ToppCell	PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	HIP1R LAMA3 CGN LRP2 HAS3 PRDM16	6.83e-05	186	165	6	bb0bfe9a015151be08a6ffc5d82896d0556d76de
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LAMA3 BMP1 TENM4 MTCL1 C5 PRDM16	6.83e-05	186	165	6	e83718fabb057100835d3357df407f283d23fe16
ToppCell	droplet-Heart-nan-24m-Endothelial-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEMA7A SLFN12 HIP1R SEC31B HAS3	6.92e-05	115	165	5	e11128262ba1e2a7053b1b6c039f1aab37d2ce27
ToppCell	COVID-19_Severe-Lymphoid_T/NK-CD8+_T_activated\|COVID-19_Severe / Disease group, lineage and cell class	HNRNPDL SYNE1 MBP LAG3 IGHA2 RAB29	7.04e-05	187	165	6	4c4c4406e16a15dedcd50bbcc2059d722a2e3d2c
ToppCell	PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	HIP1R LAMA3 LRP2 C5 HAS3 PRDM16	7.04e-05	187	165	6	db2974e2e87ac9f1c2407a371d5ed89af09fc9b7
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SYNE1 RAB22A PITPNM1 CRYBG1 FYN SORL1	7.04e-05	187	165	6	e61c1755531469dd3850c9740474b5ad4e0499c1
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MFHAS1 PEBP1 CRYBG1 WDR86 LTK SORL1	7.25e-05	188	165	6	3e3055dacc05a932f2beb114babf1dc76994e1af
ToppCell	IPF-Myeloid-cDC1\|Myeloid / Disease state, Lineage and Cell class	SEMA7A LAG3 SPECC1 TENM4 CRYBG1 FYN	7.25e-05	188	165	6	47bb6caf84f70a1cda7d09803afdfd5182772e66
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LAMA3 BMP1 TENM4 IRS2 C5 PRDM16	7.25e-05	188	165	6	4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCell	Fetal_29-31_weeks-Immune-natural_killer_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MBP IL18RAP FYN PIK3R5 CLEC2B SORL1	7.25e-05	188	165	6	6686dbba990066568aa7573e70a7db8b4758f457
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DCDC1 TNFSF10 AKAP12 LRP2 MTCL1 BICC1	7.46e-05	189	165	6	3b48b0d220cc24d5170713d61fa91f5bb6c21841
ToppCell	Fetal_29-31_weeks-Immune-natural_killer_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MBP IL18RAP FYN PIK3R5 CLEC2B SORL1	7.46e-05	189	165	6	c604da558c9f4055fb36218452463539f2a73223
ToppCell	LA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	HIP1 NBEAL1 LAMA3 SPECC1 SORT1 MACF1	7.46e-05	189	165	6	6b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCell	COVID-19-T_cells-NK_cells\|COVID-19 / group, cell type (main and fine annotations)	SYNE1 MBP IL18RAP ST8SIA6 FYN SORL1	7.46e-05	189	165	6	b699152dfbb8cd8ed724e1e5a51838f29b681b62
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HNRNPDL SYNE1 MBP LAG3 IGHA2 RAB29	7.68e-05	190	165	6	b9182c84e44aa31684b5388cf3ef4fd1b9e51de4
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HNRNPDL SYNE1 MBP LAG3 IGHA2 RAB29	7.68e-05	190	165	6	88c092a5e78ccaddf406f8fff74376bb761b9790
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	HNRNPDL SYNE1 MBP LAG3 IGHA2 RAB29	7.68e-05	190	165	6	4b42a16902d7d1494f953cc88af1e761e76bdf2c
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DMTF1 SYNE1 MBP MACF1 FYN PIK3R5	7.68e-05	190	165	6	d153a0bdedcd6865e6ee19575234a78b5d859ff1
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HNRNPDL SYNE1 MBP LAG3 IGHA2 RAB29	7.68e-05	190	165	6	9501f0995f3d52be90c02b1aa0c7d184bd788c16
ToppCell	MS-Treg-exh_CD4\|MS / Condition, Cell_class and T cell subcluster	DMTF1 DCAF15 MSL1 DROSHA KAT6B PPP6R3	8.14e-05	192	165	6	c6722bf142c84ccedd99c1a3344085aecb4cbab4
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	HIP1R LAMA3 LRP2 HAS3 PRDM16 SORL1	8.14e-05	192	165	6	b7c01e12b3e9be960a741b08835f1dfff65d0d47
ToppCell	15-Trachea-Epithelial-Intermediate_ciliated\|Trachea / Age, Tissue, Lineage and Cell class	DNAH2 MUC16 WDR38 CFAP126 BCO2 MINDY4	8.14e-05	192	165	6	9cbe961a800c981cdc742a47ed18e9c8eb6430bd
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	LAMA3 CGN LRP2 HAS3 PRDM16 SORL1	8.14e-05	192	165	6	1aa5e4d9b32013a3f272561dcb8377f6805706df
ToppCell	COVID-19-kidney-Myeloid\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HK2 MBP IL18RAP CSF2RB PIK3R5 SORL1	8.14e-05	192	165	6	0b9d22a222f1201e375f8e55cace9ef939febae4
ToppCell	severe-Myeloid-Neutrophils_3\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	HIP1 ACOX1 MSL1 MANSC1 IRS2 SORL1	8.37e-05	193	165	6	f4d43dfbf4115dd0f843ea5cf08049220342a047
ToppCell	Control-Endothelial-VE_Arterial\|World / Disease state, Lineage and Cell class	CYP1A1 ARHGAP23 TNFSF10 RALGAPA2 F8 ST8SIA6	8.37e-05	193	165	6	52c0f2c7af57436f23e0c0e0c87086c47695e2c4
ToppCell	facs-Tongue-nan-3m-Epithelial-keratinocyte\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK2 ACOX1 ZNF185 SORT1 SGPP1 AKAP13	8.37e-05	193	165	6	33437fdb417d78463caee14a9f0e094da1733829
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SYNE1 MBP LAG3 MACF1 FYN CLEC2B	8.37e-05	193	165	6	a594f89a18273797506287d9e22f72abe53e4920
ToppCell	COVID-19-lung-NK/NKT\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MBP IL18RAP FYN PIK3R5 CLEC2B SORL1	8.37e-05	193	165	6	c24b44fcc92fff42ebba6f1aff91c7aaea179e56
ToppCell	(1)_Osterolineage_cells\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	COL12A1 SEMA7A UNC5B BMP1 TENM4 BICC1	8.37e-05	193	165	6	035eeea9f77c4bf9cd85f07fa791b6c857be76b5
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	HIP1R LAMA3 LRP2 HAS3 PRDM16 SORL1	8.37e-05	193	165	6	4b8202fcfe639a73f69a13f48fc3601ade256346
ToppCell	PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	TICRR HIP1R LAMA3 STIL CGN PRDM16	8.62e-05	194	165	6	c197e4acbff42a9f0410b6801c2bfcf6160aefc1
ToppCell	severe-Myeloid-Neutrophils_3\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	HIP1 ACOX1 MSL1 MANSC1 IRS2 SORL1	8.62e-05	194	165	6	1f8edab1c8ba48bc0114429ea47aab378b5830b7
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TNFSF10 LAG3 MUC16 MANSC1 CHST4 SORL1	8.86e-05	195	165	6	2a9a36df1dbc4eac77a8ddbe939ec8a8d6c41464
ToppCell	10x5'-Lung-Lymphocytic_NK-NK_CD16\|Lung / Manually curated celltypes from each tissue	SYNE1 MBP IL18RAP RAB29 FYN CLEC2B	8.86e-05	195	165	6	e91e7f89163c615b706f3297b641b1e4c966f5e6
ToppCell	control-Lymphocytic-CD8_T_cells\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	SYNE1 MBP LAG3 RAB29 FYN CLEC2B	8.86e-05	195	165	6	55b9052336cab3e769a126ecaeef267d8e7bcaa8
ToppCell	COVID-19-lung-NK/NKT\|lung / Disease (COVID-19 only), tissue and cell type	MBP IL18RAP ST8SIA6 FYN PIK3R5 SORL1	8.86e-05	195	165	6	3ab941a369e3815f338890b116dc77aefa054098
ToppCell	facs-Aorta-Heart-3m-Endothelial-aorta_endothelial_cell\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEMA7A LAMA3 F8 SGPP1 MACF1 FYN	8.86e-05	195	165	6	3969b8d5fcec8ef1831531a781f7bbcebab5a4ba
ToppCell	control-immature_Neutrophil\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	KIAA0930 HK2 WDR7 SPECC1 VPS52 HNRNPUL2	9.11e-05	196	165	6	e34fd3e7a5b1c22a81fd3208e6d58bdb846d51c4
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD8-Tem/emra_CD8\|bone_marrow / Manually curated celltypes from each tissue	SYNE1 MBP LAG3 RAB29 FYN CLEC2B	9.11e-05	196	165	6	f23c33ad10f933250be98e8389a9aa278e876f96
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SYNE1 MBP LAG3 AKAP13 FYN CLEC2B	9.11e-05	196	165	6	17f17edadafdad9f24e88d708d7e1c765503131c
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	SYNE1 MBP LAG3 MACF1 RAB29 FYN	9.37e-05	197	165	6	836061acd7f0d5de89b16f52ec679bdf09eac9db
ToppCell	PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	HIP1R LAMA3 CGN LRP2 HAS3 PRDM16	9.37e-05	197	165	6	22b26bac3a99b20c73bfa6e6f81026d064eaa9e8
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SYNE1 DNAH2 MUC16 WDR38 CFAP126 SPAG16	9.37e-05	197	165	6	91637bdeab85024b5a02d1066f76cb803a2d6420
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DCDC1 TNFSF10 MFHAS1 PEBP1 SPAG16 BICC1	9.37e-05	197	165	6	7e93a97b5ac5ae2f77a4b3141082a1463fed00dd
Drug	2,3,4-trichlorophenol	CYP1A1 CYP1A2 ACOX1	6.71e-06	6	160	3	CID000027582
Drug	3-(4-(4-chlorophenyl-4-hydroxypiperidino)methyl)indole	CYP1A1 CYP1A2 FYN	6.71e-06	6	160	3	ctd:C104750
Drug	Polychlorinated Biphenyls	HNRNPDL RAF1 CYP1A1 CYP1A2 COL12A1 ACOX1 ST3GAL3 HUWE1 SEC31B ARAF AKAP12 PLAA PEBP1 MACF1 RPA1 CLEC2B	1.06e-05	633	160	16	ctd:D011078
Drug	2,3,5-trichlorophenol	CYP1A1 CYP1A2 C5	2.77e-05	9	160	3	CID000013619
Drug	5-Azachrysene	CYP1A1 CYP1A2 SYNE1 TMPRSS11D	4.22e-05	28	160	4	CID000344234
Drug	2-methoxy-4-aminoazobenzene	CYP1A1 CYP1A2	4.91e-05	2	160	2	ctd:C053767
Drug	3,4,3',4'-tetrachloroazoxybenzene	CYP1A1 CYP1A2	4.91e-05	2	160	2	ctd:C013280
Drug	sulfur dichloride	SYNE1 PES1	4.91e-05	2	160	2	CID000025353
Drug	cloflucarban	CYP1A1 CYP1A2	4.91e-05	2	160	2	ctd:C005055
Drug	musk xylene	CYP1A1 CYP1A2	4.91e-05	2	160	2	ctd:C031447
Drug	sesamex	CYP1A1 CYP1A2	4.91e-05	2	160	2	ctd:C100180
Drug	Canthaxanthin	CYP1A1 CYP1A2	4.91e-05	2	160	2	ctd:D016644
Drug	Pigment Yellow 74	CYP1A1 CYP1A2	4.91e-05	2	160	2	CID000022829
Drug	pyridoxal isonicotinoyl hydrazone	CYP1A1 CYP1A2	4.91e-05	2	160	2	ctd:C021079
Drug	nitroaniline	CYP1A1 CYP1A2	4.91e-05	2	160	2	ctd:C008625
Drug	7H-dibenzo(c,g)carbazole	CYP1A1 CYP1A2	4.91e-05	2	160	2	ctd:C013478
Drug	2,7-dinitrofluorene	CYP1A1 CYP1A2	4.91e-05	2	160	2	ctd:C085049
Drug	beta-apo-8'-carotenal	CYP1A1 CYP1A2	4.91e-05	2	160	2	ctd:C110652
Drug	propachlor	CYP1A1 CYP1A2	4.91e-05	2	160	2	ctd:C011088
Drug	allocryptopine	CYP1A1 CYP1A2	4.91e-05	2	160	2	ctd:C109505
Drug	2,7-FAA	CYP1A1 CYP1A2	4.91e-05	2	160	2	CID000009352
Drug	protopine	CYP1A1 CYP1A2	4.91e-05	2	160	2	ctd:C009093
Drug	2,3-dichlorobutane	CYP1A1 CYP1A2 AKAP13	5.39e-05	11	160	3	CID000024233
Drug	1-chlorohexane	CYP1A1 CYP1A2 AKAP13	5.39e-05	11	160	3	CID000010992
Drug	Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; PC3; HT_HG-U133A	TNFSF10 UNC5B ACOX1 HNRNPUL2 AKAP13 ZFR IRS2 FYN	5.92e-05	189	160	8	6649_DN
Drug	Flavoxate hydrochloride [3717-88-2]; Down 200; 9.4uM; PC3; HT_HG-U133A	CYP1A2 KIAA0930 HIP1R BMP1 HNRNPUL2 NLE1 AKAP13 ZFR	7.92e-05	197	160	8	6326_DN
Drug	sulphoxide	CYP1A2 SYNE1 LTB4R2 KYAT1 ACTL7B ALDH7A1	8.01e-05	101	160	6	CID000008442
Drug	Chlorthalidone [77-36-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A	HIP1 GPR19 HIP1R PITPNM1 BMP1 NLE1 FYN ALDH7A1	8.20e-05	198	160	8	6800_UP
Drug	ethanol	CYP1A1 CYP1A2 SLC29A3 RHBDF1 LDHAL6A ACOX1 MBP ARAF NT5C1A PPP2R1A CSF2RB SCNN1D C4A IRS2 RPA1 PIK3R5 ALDH7A1	8.77e-05	837	160	17	CID000000702
Drug	3,4,5,3',4',5'-hexachlorobiphenyl	CYP1A1 CYP1A2 FYN	9.25e-05	13	160	3	ctd:C027309
Drug	clozapine N-oxide	CYP1A1 CYP1A2 SLC6A5	9.25e-05	13	160	3	CID000036727
Drug	Span 40	RAF1 STK36 ARAF	1.17e-04	14	160	3	CID000014927
Drug	bromide	CYP1A1 CYP1A2 RHBDF1 LDHAL6A SYNE1 KYAT1 VPS13A ALDH7A1 ALOX15B	1.18e-04	267	160	9	CID000000259
Drug	4-bromophenol	CYP1A1 CYP1A2 SYNE1 NT5C1A AKAP13	1.35e-04	70	160	5	CID000007808
Drug	AC1L7SPV	CYP1A1 CYP1A2 ALDH7A1	1.46e-04	15	160	3	CID000366354
Drug	2,3-diaminotoluene	CYP1A1 CYP1A2	1.47e-04	3	160	2	ctd:C100420
Drug	2-amino-1-methyl-6-phenyl-1H-imidazo(4,5-b)pyridine	CYP1A1 CYP1A2	1.47e-04	3	160	2	ctd:C522525
Drug	2-amino-1,7-dimethylimidazo(4,5-g)quinoxaline	CYP1A1 CYP1A2	1.47e-04	3	160	2	ctd:C519626
Drug	scutellarein	CYP1A1 CYP1A2	1.47e-04	3	160	2	ctd:C458179
Drug	genkwanin	CYP1A1 CYP1A2	1.47e-04	3	160	2	ctd:C014568
Drug	1-methoxyrutaecarpine	CYP1A1 CYP1A2	1.47e-04	3	160	2	CID005319487
Drug	Suppressor Factors, Immunologic	CYP1A1 CYP1A2	1.47e-04	3	160	2	ctd:D013491
Drug	alyssin	CYP1A1 CYP1A2	1.47e-04	3	160	2	ctd:C524316
Drug	2-oxohexyl isothiocyanate	CYP1A1 CYP1A2	1.47e-04	3	160	2	ctd:C524315
Drug	2-aminothiophenol	C4A C4B	1.47e-04	3	160	2	ctd:C005464
Drug	Trichloroepoxypropane	CYP1A1 CYP1A2	1.47e-04	3	160	2	ctd:D014239
Drug	3-aminofluorene	CYP1A1 CYP1A2	1.47e-04	3	160	2	CID000022818
Drug	1-aminofluorene	CYP1A1 CYP1A2	1.47e-04	3	160	2	CID000022817
Drug	ethyl bromodifluoroacetate	SYNE1 ALDH7A1	1.47e-04	3	160	2	CID000069585
Drug	2,2',4,6'-tetramethoxystilbene	CYP1A1 CYP1A2	1.47e-04	3	160	2	ctd:C541980
Drug	6-nitrobenzo(a)pyrene	CYP1A1 CYP1A2	1.47e-04	3	160	2	ctd:C034699
Drug	chlortoluron	CYP1A1 CYP1A2	1.47e-04	3	160	2	ctd:C007033
Drug	Aminoquinolines	CYP1A1 CYP1A2	1.47e-04	3	160	2	ctd:D000634
Drug	7-(deoxyadenosin-N(6)--yl)aristolactam II	CYP1A1 CYP1A2	1.47e-04	3	160	2	ctd:C405699
Drug	1,2,3,7,8-pentachlorodibenzofuran	CYP1A1 CYP1A2	1.47e-04	3	160	2	ctd:C057584
Drug	caldarchaeol	STK36 C4A	1.47e-04	3	160	2	CID005388885
Drug	7-nitrobenzanthracene	CYP1A1 CYP1A2	1.47e-04	3	160	2	ctd:C038954
Drug	1,2-dichloroethylene	CYP1A1 CYP1A2	1.47e-04	3	160	2	ctd:C035384
Drug	N-(5-(3-dimethylaminobenzamido)-2-methylphenyl)-4-hydroxybenzamide	RAF1 CYP1A1	1.47e-04	3	160	2	ctd:C121825
Disease	5-hydroxy-2-methylpyridine sulfate measurement	CYP1A1 CYP1A2	3.00e-05	2	162	2	EFO_0801051
Disease	serum clozapine measurement	CYP1A1 CYP1A2	3.00e-05	2	162	2	EFO_0600041
Disease	Kidney Neoplasm	RAF1 CYP1A1 TNFSF10 KYAT1	6.86e-05	40	162	4	C0022665
Disease	coffee consumption, cups of coffee per day measurement	CYP1A1 CYP1A2 PDSS2	8.63e-05	16	162	3	EFO_0004330, EFO_0006782
Disease	Malignant neoplasm of breast	RAF1 CYP1A1 RAPH1 TNFSF10 SYNE1 ARAF AKAP12 HNRNPL BMP1 FKTN OTOGL SLC6A5 FAM217B NLE1 MACF1 KAT6B SORL1	9.23e-05	1074	162	17	C0006142
Disease	Malignant neoplasm of kidney	RAF1 CYP1A1 TNFSF10 KYAT1	1.09e-04	45	162	4	C0740457
Disease	X-21286 measurement	CYP1A1 CYP1A2	1.78e-04	4	162	2	EFO_0800804
Disease	porphyria cutanea tarda (is_implicated_in)	CYP1A1 CYP1A2	4.43e-04	6	162	2	DOID:3132 (is_implicated_in)
Disease	alcohol consumption measurement	CYP1A1 CYP1A2 RC3H2 COL12A1 RAPH1 DNAH2 FAM114A2 TENM2 DERA DEFB112 CLN3 TNRC6A HAS3 RAB29 PRDM16 PPP6R3 SORL1	5.03e-04	1242	162	17	EFO_0007878
Disease	Huntington disease, disease progression measurement	TENM2 ST8SIA6 MINDY4	5.91e-04	30	162	3	EFO_0008336, MONDO_0007739
Disease	Chronic Obstructive Airway Disease	CYP1A1 CYP1A2 MTCL1	7.85e-04	33	162	3	C0024117
Disease	Complement deficiency disease	C4A C4B C5	7.85e-04	33	162	3	C0272242
Disease	Chronic Airflow Obstruction	CYP1A1 CYP1A2 MTCL1	7.85e-04	33	162	3	C1527303
Disease	plasma clozapine measurement	CYP1A1 CYP1A2	8.21e-04	8	162	2	EFO_0600038
Disease	Moderate albuminuria	CYP1A1 CYP1A2 PDSS2 ST8SIA6	1.00e-03	80	162	4	HP_0012594
Disease	advanced glycation end-product measurement	CYP1A1 CYP1A2	1.05e-03	9	162	2	EFO_0007819
Disease	Graves' disease (is_implicated_in)	CYP1A1 C4A C4B	1.28e-03	39	162	3	DOID:12361 (is_implicated_in)
Disease	theophylline measurement	CYP1A1 CYP1A2	1.31e-03	10	162	2	EFO_0021180
Disease	sweet beverage consumption measurement	CYP1A1 CYP1A2	1.31e-03	10	162	2	EFO_0010090
Disease	1,7-dimethylurate measurement	CYP1A1 CYP1A2	1.31e-03	10	162	2	EFO_0021512
Disease	Stomach Neoplasms	ATR HNRNPL PPP2R1A CLN3 IRS2 FYN ALDH7A1	1.32e-03	297	162	7	C0038356
Disease	Glioma	RAF1 ATR TNFSF10 DMXL1	1.37e-03	87	162	4	C0017638
Disease	Malignant neoplasm of stomach	ATR HNRNPL PPP2R1A CLN3 IRS2 FYN ALDH7A1	1.40e-03	300	162	7	C0024623
Disease	1-methylxanthine measurement	CYP1A1 CYP1A2	1.59e-03	11	162	2	EFO_0021174
Disease	plasma N-desmethylclozapine measurement	CYP1A1 CYP1A2	1.59e-03	11	162	2	EFO_0600039
Disease	5-acetylamino-6-amino-3-methyluracil measurement	CYP1A1 CYP1A2	1.59e-03	11	162	2	EFO_0800951
Disease	Familial dilated cardiomyopathy	RAF1 FKTN PRDM16	1.82e-03	44	162	3	C0340427
Disease	paraxanthine measurement	CYP1A1 CYP1A2	1.91e-03	12	162	2	EFO_0021178
Disease	small vessel stroke	NBEAL1 RALGAPA2 WDR12 PRDM16	1.96e-03	96	162	4	EFO_1001504
Disease	uric acid measurement	DCDC1 XPNPEP2 TENM2 PTPDC1 LRP2 AKAP13 MINDY4 RPA1 RAB29 BICC1	2.07e-03	610	162	10	EFO_0004761
Disease	Disease Exacerbation	HNRNPL PPP2R1A CLN3 CRYBG1 ALDH7A1	2.22e-03	165	162	5	C0235874
Disease	Migraine Disorders	ATP1A2 PRDM16	2.25e-03	13	162	2	C0149931
Disease	cerotoylcarnitine (C26) measurement	ST3GAL3 PPP6R3	2.25e-03	13	162	2	EFO_0800542
Disease	sodium measurement	CYP1A1 CYP1A2 DCDC1 MEN1	2.54e-03	103	162	4	EFO_0009282
Disease	triacylglycerol 48:4 measurement	MBP TENM4	2.61e-03	14	162	2	EFO_0010407
Disease	femoral neck bone geometry	HK2 PPP6R3	2.61e-03	14	162	2	EFO_0004511
Disease	Tourette syndrome	MUC16 TENM2 TENM4	2.64e-03	50	162	3	EFO_0004895
Disease	electrocardiography	RAF1 OR8B4 MFHAS1 SCYL1 ATP1A2 KAT6B RAB29 FYN PRDM16	2.73e-03	530	162	9	EFO_0004327
Disease	schizophrenia (biomarker_via_orthology)	MBP ASH2L	3.00e-03	15	162	2	DOID:5419 (biomarker_via_orthology)
Disease	1,3,7-trimethylurate measurement	CYP1A1 CYP1A2	3.00e-03	15	162	2	EFO_0021172
Disease	Hepatomegaly	CYP1A1 CYP1A2 SLC29A3	3.28e-03	54	162	3	C0019209
Disease	Metastatic melanoma	SCYL1 MAP3K10 FYN	3.28e-03	54	162	3	C0278883
Disease	body mass index, osteoarthritis	SEMA7A RAPH1 WDR12	3.28e-03	54	162	3	EFO_0004340, MONDO_0005178
Disease	pneumonia (is_implicated_in)	CYP1A1 C5	3.42e-03	16	162	2	DOID:552 (is_implicated_in)
Disease	cancer (implicated_via_orthology)	RAF1 TRIP12 ARAF MACF1 LTK FYN	3.73e-03	268	162	6	DOID:162 (implicated_via_orthology)
Disease	muscular dystrophy (is_implicated_in)	SYNE1 FKTN	3.86e-03	17	162	2	DOID:9884 (is_implicated_in)
Disease	Antibody Deficiency Syndrome	C4A C5	3.86e-03	17	162	2	C0003257
Disease	caffeine metabolite measurement	CYP1A1 CYP1A2	4.82e-03	19	162	2	EFO_0007872
Disease	systemic lupus erythematosus (is_implicated_in)	CYP1A1 C4A C4B	4.85e-03	62	162	3	DOID:9074 (is_implicated_in)
Disease	non-lobar intracerebral hemorrhage	NBEAL1 ST3GAL3 WDR12	5.07e-03	63	162	3	EFO_0010178
Disease	diet measurement	CYP1A1 CYP1A2 MFHAS1 RALGAPA2 TENM2 RMI1 DEFB112 TENM4 ST8SIA6 CLN3 TNRC6A PRDM16 SORL1	5.35e-03	1049	162	13	EFO_0008111

Protein segments in the cluster

Peptide	Gene	Start	Entry
LVKRLAGGDWFTSRT	PPP2R1A	131	P30153
SSSVRTASELGGLWD	C2orf16	741	Q68DN1
FKLRSIGWGEEFSLS	ZBTB8OS	121	Q8IWT0
GKSRGSQRWESSASF	ARHGEF18	1251	Q6ZSZ5
RKTSVWTGGSILASL	ACTL7B	376	Q9Y614
GTWKISARFSDGLES	C4B	211	P0C0L5
ASSGARALKTLRSWG	NT5C1A	286	Q9BXI3
SSSIFTKDLGRIFRW	ALDH7A1	456	P49419
TEGEGVSTWESFKRL	AKAP12	751	Q02952
DKEASLGLWRTGSFL	GPR15	91	P49685
FTTGRWTLGSATCKV	GPR19	126	Q15760
DSEWKSGTKVSRTFS	AKAP13	1736	Q12802
ASKDVGSLKVSSGAW	CRYBA2	136	P53672
FGDTRLLSASTRAWK	SPECC1	926	Q5M775
GVGSKGWRDVTTFFS	ARFGAP1	281	Q8N6T3
DTGWVKAAIGSVFSS	ACSM4	271	P0C7M7
EFSSISKWSEGTGTF	C1orf147	186	Q96MC9
TISSVGSWRGRSSKS	PDSS2	31	Q86YH6
TSSRLWLKFVSDGSI	BMP1	521	P13497
TSKIRGKAFSDGISW	BCO2	311	Q9BYV7
VRTPTNTWSGLGFSK	BICC1	751	Q9H694
WATIGAALGRSASSV	DMTF1	246	Q9Y222
GSAEGNIKIWSLSTF	DMXL1	2946	Q9Y485
RKLLASWVSGSSGRS	CDAN1	806	Q8IWY9
TKWFTADTFGIDTSS	ASH2L	121	Q9UBL3
ILSSASWGGTIEKSK	NBEAL1	746	Q6ZS30
FWGSSKRLSQISAGE	NBEAL1	2671	Q6ZS30
LLSSFSVGEGWKRRT	R3HCC1	61	Q9Y3T6
IISKWGAISRSSRTG	RC3H2	901	Q9HBD1
DFGLATVKSRWSGSQ	RAF1	486	P04049
LGDTGVGKSSIVWRF	RAB22A	11	Q9UL26
SIVSSVFSEAWKRGT	RAPH1	571	Q70E73
RFSKENGFTGWTETS	RAB29	141	O14966
GAGFDTVTTAISWSL	CYP1A1	316	P04798
GAGFDTVTTAISWSL	CYP1A2	316	P05177
KGYSESAWARSTTTR	MTCL1	1736	Q9Y4B5
GSAIASSSLATEWVK	ISCU	96	Q9H1K1
VTSGLTGWAAFAAKT	INTS12	286	Q96CB8
FIGGLSWDTSKKDLT	HNRNPDL	151	O14979
EGRSKAFSTWGSHII	OR8B4	231	Q96RC9
SSSSSWGMARGSIFK	KAT6B	601	Q8WYB5
FITGWSPVGTKLDSS	MEN1	146	O00255
EFIGGSTFWTKEVTT	MUC16	1761	Q8WXI7
WLTGLSGAGKTTISF	PAPSS2	46	O95340
SVSIGKWSFSGSEAS	DCDC1	671	M0R2J8
KWSFSGSEASSRSQI	DCDC1	676	M0R2J8
VGLFSSTLLGAWSDS	SLC46A1	96	Q96NT5
WKGLSRTETTGRSSQ	IL18RAP	581	O95256
RLSLFSKSSDVWSFG	MAP3K10	276	Q02779
SEDWKLVRSASFSRG	LAMA3	2761	Q16787
KGIEVTSWTADASRG	MFHAS1	456	Q9Y4C4
AKSSRFSWLTLISEG	ERVFC1-1	251	P60608
TTWTTSGLKSQGRLS	KIAA1109	4426	Q2LD37
SLSGTGRSLVGSWLK	KIAA0930	351	Q6ICG6
SFLVSWTKGFKSSGV	HK2	166	P52789
KEISRTSNWGSSFSE	LINC00474	21	Q9P2X8
LEGIFTSKTDSWSFG	LTK	696	P29376
TSISWDGLDSGKLYT	PEBP1	51	P30086
TKLQRWDLSGSGSSS	FAM217B	301	Q9NTX9
TLWSGARSTYGVTKG	HNRNPUL2	276	Q1KMD3
ISWRDTLSQKFGSSD	MANSC1	166	Q9H8J5
TEASETRKWTGTQFG	KNOP1	346	Q1ED39
ESSWGKNVSSTESGR	F8	976	P00451
AGVGTRSFLTAKWTP	LAG3	286	P18627
ISGRIFWSDATQGKT	LRP2	1476	P98164
STLSFWSQSKFGGLE	PTPDC1	451	A2A3K4
TATAGTLAASEGRWK	MSL1	186	Q68DK7
QKGTTVGRSFSLSWR	RALGAPA2	686	Q2PPJ7
AWKSGETSVRFTAGR	HUWE1	1641	Q7Z6Z7
ESANVKISGTFSSGW	MACF1	2026	Q9UPN3
KISGTFSSGWTVRLP	MACF1	2031	Q9UPN3
KSSWGRTRSLGGLIS	IRS2	1281	Q9Y4H2
TWSNSRGEGKLFSLE	RPA1	211	P27694
TSGKVVTATLWGEDA	RPA1	351	P27694
GLKAFTSWTANTGIE	ACOX1	376	Q15067
GDFGLATVKTRWSGA	ARAF	446	P10398
GATFDKRSPTWTALS	ATP1A2	406	P50993
LAADGKSTTWSVRLG	ATR	1791	Q13535
SRWTEGLISASKAVG	HIP1R	866	O75146
SWEVRKEVASSVSFG	CSF2RB	261	P32927
LKITEVTSEGFRGTW	COL12A1	1661	Q99715
SKWSVGSAFRVPDTL	DMRT3	326	Q9NQL9
GRFTIKSDVWSFGIL	FYN	441	P06241
ITFSRWKSCTAIGGR	DEFB112	46	Q30KQ8
GGSASTWLTAFALRV	C5	1071	P01031
TSFPWSSIKGFISEA	CATIP	161	Q7Z7H3
LTSRTTAGAASLTKW	CFAP126	81	Q5VTH2
SKSKGSRIGFDSTQW	FKTN	41	O75072
GSWGKSILSSASATV	FAM114A2	86	Q9NRY5
SQGKGRGLSLSRFSW	MBP	236	P02686
SSKSGNLLETSEVGW	CEP192	1141	Q8TEP8
SGKSERSSSGLLEWE	HNRNPL	536	P14866
SDGWKFEQLVSIGSS	KCTD5	176	Q9NXV2
LTGLRDASGATFTWT	IGHA2	136	P01877
FAIATINKSGWGTSG	HAS3	456	O00219
DSFSTKSCRVSGGSW	CRYBG1	1441	Q9Y4K1
TTLSEVGFGRWSTFL	C4orf54	651	D6RIA3
AGGIRSAKDSLAWLS	DERA	256	Q9Y315
TGSGKTASWRILQAS	DNAH2	2086	Q9P225
ESAFKLSTGTSRWPS	SCNN1D	621	P51172
LTEVKGQTSGSVWSS	DCAF15	536	Q66K64
GTWKISARFSDGLES	C4A	211	P0C0L4
KTTFGFSLAWDGISG	OTOGL	226	Q3ZCN5
GSWGKSLLSSASATV	FAM114A1	131	Q8IWE2
LKARTGGSQWASSDS	FAM83G	796	A6ND36
AGTWDKVSVSIVGTR	ALOX15B	16	O15296
SSSKDGSVRIWDTTA	NLE1	221	Q9NVX2
ALVKVDTSSWTRGFF	SLC29A3	151	Q9BZD2
ELSSQGFWKTGIRSD	DROSHA	841	Q9NRR4
LWRTSDLGKSFKTIG	SORT1	286	Q99523
VTSRGIGNWSDSKSI	SORL1	1726	Q92673
RSFLAWGVQTFTSGK	TRIM49	326	P0CI25
SFLTWLERGEAKASS	SYNE1	1666	Q8NF91
GWAVTGVSSLTSKLI	SCYL1	571	Q96KG9
FSLSAAWGGLITLSS	SLC6A5	476	Q9Y345
ERVTFVSRALKWSSG	GET4	121	Q7L5D6
VSRALKWSSGGSGKL	GET4	126	Q7L5D6
ETLLSWKTSRATGTA	LTB4R2	11	Q9NPC1
LSSSGGIWSITAKVS	RMI1	521	Q9H9A7
WERTLTIGSAGKTFS	KYAT1	236	Q16773
TIGSAGKTFSATGWK	KYAT1	241	Q16773
AWLKVTGATSESGAF	PRDM16	1256	Q9HAZ2
SRWTEGLISASKAVG	HIP1	866	O00291
IRRGTADWFGVSKDS	RHBDF1	81	Q96CC6
GAAFASSWKTGLATS	SLC39A4	516	Q6P5W5
SVWVGGSILASLSTF	POTEJ	1001	P0CG39
ALGIFSFTLDTWSTS	SGPP1	301	Q9BX95
GGKRFSTSRQTLTWI	SHKBP1	26	Q8TBC3
WRTKGVTAYRLSTGL	ST8SIA6	311	P61647
ERVSASDGFWKSVAT	ST3GAL3	246	Q11203
TGLLATKSDETGWTT	TENM2	1686	Q9NT68
KLVWGSFGSGLLESS	SEC31B	71	Q9NQW1
GILASELKSSWAKSG	STK36	356	Q9NRP7
SSSLSLRERWTVFKG	CLN3	266	Q13286
DWASEAEKTSGGLSR	CGN	896	Q9P2M7
LVLSSWRSGSSFVGQ	CHST4	46	Q8NCG5
WGLQGTSFSRKIRTS	CNBD2	356	Q96M20
RTGQWVDGATFTKSF	CLEC2B	101	Q92478
LFFDASTSGLRWSSG	CLEC20A	71	Q6ZU45
TSTSGAFWKGSELAT	PITPNM1	796	O00562
RDWIATSGISTTFPK	TMPRSS11D	236	O60235
LIRGFGSSWKSSVES	VPS52	641	Q8N1B4
KGVSIAVSTGASLFW	STIL	786	Q15468
IVKFTGSDSWSIFGE	ZNF77	71	Q15935
EASSWGQFGLSSRKR	TICRR	1761	Q7Z2Z1
LAKSRFSGEGKNWSS	VPS13A	1746	Q96RL7
DAGWRTSLSETSKAR	MINDY4	126	Q4G0A6
IIRSFGGEVSWDKSL	PES1	346	O00541
IIYSKGAISGRSRWS	PIK3R5	731	Q8WYR1
SITLRWKTSFEDGSG	HSPA4L	401	O95757
LRSFFTDGSLDSWGT	ARHGAP23	651	Q9P227
RSFLAWGVQTFTSGK	TRIM49C	326	P0CI26
SSADKTLSIWDARTG	SPAG16	496	Q8N0X2
GKFGTLLSGSWDTTA	PLAA	121	Q9Y263
GRITSRIFADGKTWS	TENM4	1911	Q6N022
SVRKGSLIFSRSWSV	SLFN12	416	Q8IYM2
GGESSLSVSKWNTFL	SEMA7A	271	O75326
VAWSSAGTTKSRRAY	UNC5B	131	Q8IZJ1
KISGWFRSILSDKTS	SLC30A7	21	Q8NEW0
SASGLLASGSWDKTI	WDR38	201	Q5JTN6
AAAATAAWTGTTFTK	ZFR	296	Q96KR1
FTGSTWQEKVSGVRS	XPNPEP2	211	O43895
RSFLAWGAQTFTSGK	TRIM49B	326	A6NDI0
FLDSKASAGISDSSW	VSIG10L	66	Q86VR7
TGSYDKTSRIWSLEG	WDR12	116	Q9GZL7
SVVKSWGFRAGETEA	nan	141	Q6ZVU0
ALGRKINSWESSRSG	TNFSF10	146	P50591
QSKTGGSSKFDWAAR	TRIP12	251	Q14669
KETGWASFSEFTSSL	PPP6R3	716	Q5H9R7
LTGSEDGTARLWSTA	WDR86	31	Q86TI4
TGGDFVSSDKVIIWT	WDR7	261	Q9Y4E6
SADGGRTKASRAIWI	ZNF185	246	O15231
DRSVSGWNELGKTSS	TNRC6A	881	Q8NDV7
TGGYKWSTALALSIT	TM2D3	181	Q9BRN9
RSPSSTLGLSWFKAG	nan	46	Q8N9W7
RSPSSTLGLSWFKAG	nan	46	A6NDX4
RIQFSGRKSTGSWVT	nan	31	Q8TCH9
GYTSWGISLSVADLT	LDHAL6A	246	Q6ZMR3
FSGVTKADRTTAEVW	LRRC51	161	Q96E66